ArticleNeuropharmacology2017

Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease.

Natalia Mast et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.